Researchers have found that new myelin-making cells are constantly being made in the brain and spinal cord, even in the ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.

Multiple sclerosis (MS) is primarily recognised as a chronic demyelinating disease of the central nervous system, yet its impact extends to the autonomic nervous system (ANS), which governs vital ...

May 30, 2025, is the 17 th annual World Multiple Sclerosis Day, a day when the global medical community focuses on those living with Multiple Sclerosis (MS), a complex and frequently misunderstood ...

Alcohol and MS both affect the central nervous system. Short-term effects of drinking can include balance issues, fatigue, ...

Both Guillain-Barré syndrome and multiple sclerosis involve an autoimmune attack on the nervous system. Guillain-Barré syndrome affects the peripheral nervous system, while multiple sclerosis impacts ...

Silent cells deep in your spinal cord may hold a surprising key to healing after devastating injuries and brain disease. A ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...

Ever had that moment when a family member gets diagnosed with multiple sclerosis and suddenly everyone’s wondering — am I next? It’s a scary thought that sends many people down internet rabbit holes, ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now ...